This product is provided in a capsule-based oral research format for laboratory investigation and comparative research applications
Administered in cycles of 3-6 daily injections, patients treated with BPC-157 report up to 90 % pain reduction lasting months to years after a single cycle
For ligament work, the canonical reference is Cerovecki and colleagues 2010 study of medial collateral ligament transection in rats, in which intraperitoneal, oral (drinking water), and topical BPC-157 administration each produced consistent improvements in functional, biomechanical, macroscopic, and histological healing endpoints over a 90-day window (Cerovecki et al., 2010)
AOD-9604 does not increase hunger or raise cortisol
Its incredible how easy this journey has becomeIm feeling healthier and more confident than ever